Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

238 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Barriers to treatment for visceral leishmaniasis in hyperendemic areas: India, Bangladesh, Nepal, Brazil and Sudan.
Thornton SJ, Wasan KM, Piecuch A, Lynd LL, Wasan EK. Thornton SJ, et al. Among authors: wasan km, wasan ek. Drug Dev Ind Pharm. 2010 Nov;36(11):1312-9. doi: 10.3109/03639041003796648. Drug Dev Ind Pharm. 2010. PMID: 20545513 Review.
Formulation and physiological and biopharmaceutical issues in the development of oral lipid-based drug delivery systems.
Wasan KM. Wasan KM. Drug Dev Ind Pharm. 2001 Apr;27(4):267-76. doi: 10.1081/ddc-100103726. Drug Dev Ind Pharm. 2001. PMID: 11411894 Review.
Differences in the method by which plasma is separated from whole blood influences amphotericin B plasma recovery and distribution following amphotericin B lipid complex incubation within whole blood.
Ramaswamy M, Wasan KM. Ramaswamy M, et al. Among authors: wasan km. Drug Dev Ind Pharm. 2001 Sep;27(8):871-5. doi: 10.1081/ddc-100107252. Drug Dev Ind Pharm. 2001. PMID: 11699840
The role of lymphatic transport in enhancing oral protein and peptide drug delivery.
Wasan KM. Wasan KM. Drug Dev Ind Pharm. 2002 Oct;28(9):1047-58. doi: 10.1081/ddc-120014573. Drug Dev Ind Pharm. 2002. PMID: 12455465 Review.
Development of novel water-soluble phytostanol analogs: disodium ascorbyl phytostanyl phosphates (FM-VP4): preclinical pharmacology, pharmacokinetics and toxicology.
Ng AW, Lukic T, Pritchard PH, Wasan KM. Ng AW, et al. Among authors: wasan km. Cardiovasc Drug Rev. 2003 Fall;21(3):151-68. doi: 10.1111/j.1527-3466.2003.tb00113.x. Cardiovasc Drug Rev. 2003. PMID: 12931251 Review.
Effect of lipid excipients on in vitro pancreatic lipase activity.
Subramanian R, Wasan KM. Subramanian R, et al. Among authors: wasan km. Drug Dev Ind Pharm. 2003 Sep;29(8):885-90. doi: 10.1081/ddc-120024184. Drug Dev Ind Pharm. 2003. PMID: 14570309
Determining the critical micelle concentration of a novel lipid-lowering agent, disodium ascorbyl phytostanyl phosphate (FM-VP4), using a fluorescence depolarization procedure.
Wasan KM, Choo E, Sivak O, Wallis S, Letchford K, Burt HM, Stewart DJ, Lukic T. Wasan KM, et al. Drug Dev Ind Pharm. 2004 Aug;30(7):725-30. doi: 10.1081/ddc-120039509. Drug Dev Ind Pharm. 2004. PMID: 15491050
Development and characterization of liposomal disodium ascorbyl phytostanyl phosphates (FM-VP4).
Ng AW, Lukic T, Pritchard PH, Wasan KM. Ng AW, et al. Among authors: wasan km. Drug Dev Ind Pharm. 2004 Aug;30(7):739-58. doi: 10.1081/ddc-120039570. Drug Dev Ind Pharm. 2004. PMID: 15491052
Potential mechanisms by which Peceol increases the gastrointestinal absorption of amphotericin B.
Risovic V, Sachs-Barrable K, Boyd M, Wasan KM. Risovic V, et al. Among authors: wasan km. Drug Dev Ind Pharm. 2004 Aug;30(7):767-74. doi: 10.1081/ddc-120039793. Drug Dev Ind Pharm. 2004. PMID: 15491054
Competitive displacement of clozapine from plasma proteins in normolipidemic and hyperlipidemic plasma samples: clinical implications.
Procyshyn RM, Ho T, Wasan KM. Procyshyn RM, et al. Among authors: wasan km. Drug Dev Ind Pharm. 2005 May;31(4-5):331-7. doi: 10.1081/ddc-54305. Drug Dev Ind Pharm. 2005. PMID: 16093198
238 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback